Highline Wealth Partners
WST icon

Highline Wealth Partners’s West Pharmaceutical WST Stock Holding History

Highline Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.82K Buy
13
+6
+86% +$2.12K ﹤0.01% 920
2026
Q2 		$2.51K Buy
+7
New +$2.14K ﹤0.01% 1136
2025
Q1 		– Sell
-3
Closed -$983 – 1055
2024
Q4 		$983 Buy
+3
New +$944 ﹤0.01% 532

Other funds holding WST

Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Highline Wealth Partners's WST Position: Q3 2026 in Review

Highline Wealth Partners increased its West Pharmaceutical (WST) stake by 86% in Q3 2026, buying an estimated $2.12K and bringing the position to 13 shares worth $4.82K. The position accounts for ﹤0.01% of the portfolio, ranked #920.

Highline Wealth Partners first reported a position in WST in Q4 2024 and has held it in 3 quarters since. 189 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Highline Wealth Partners held 13 shares of West Pharmaceutical worth $4.82K as of Q3 2026.
  • Highline Wealth Partners bought 6 West Pharmaceutical shares in Q3 2026, an estimated $2.12K.
  • West Pharmaceutical made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #920 holding.
  • Highline Wealth Partners first reported a position in West Pharmaceutical in Q4 2024 and has held it in 3 quarters since.
  • 189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.